In the randomized, double-blind, placebo-controlled trial, they observed high baseline activity of catalase and GPx, but after treatment with coenzyme Q10, the activity of the mentioned enzymes decreased significantly in T2DM patients with NPDR [91]. The gene discussed is CAT; the disease is type 2 diabetes mellitus.